MSB 2.51% 97.0¢ mesoblast limited

Ann: MSB Completes Financing For Covid-19 ARDS Manufacturing, page-109

  1. 1,887 Posts.
    lightbulb Created with Sketch. 2456
    "If there is anything negative coming from the front line re: the administered Rem-L in phase 2/3 patients, I am yet to see it."

    I haven't seen anything at all one way or the other. The Mount Sinai Twitter feed has a number of stories about people coming off ventilators, but no mention of 'revolutionary' treatments or trials.

    I've tried searching by the other centres involved in the trial, thought maybe there'd be some local media from some of the locations, but again, can't find anything, positive or negative.

    I've tried looking at the death rates around specific centres to see if there has been a decrease, but without knowing the sample size at each centre it's impossible to determine if any rise or fall is due to efficacy of the trial (or not).

    The probability of the results from the 12 person trial certainly suggested to me a high likelihood of success in the current trial. I'm frankly surprised good news hasn't started to leak out - which is why I've been specifically searching for it, both through anecdote and through the public data.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.